Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q3 2024 · 10-Q
Revenue$339.85M$339.85M+7.8% vs Q3 2023 Net Income$28.44M$28.44M+10.1% vs Q3 2023 EPS Diluted$0.48$0.48+9.1% vs Q3 2023 Gross Profit$157,535,000+10.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$47,333,000−7.3% Free Cash Flowderived$37,974,000−10.6% Margins · derivedGross margin46.4%+1.2 pt vs Q3 2023
Operating margin11.0%−0.2 pt vs Q3 2023
Net margin8.4%+0.2 pt vs Q3 2023
ended Sep 30, 2024 · filed Oct 30, 2024 · 30 d after period end